As the federal government mulls the decision of whether to reclassify marijuana as a less dangerous drug, industry leaders in Washington state are considering what the changes could mean to local consumers and researchers. In May, President Biden announced the Department of Justice was considering a historic change in the way it classifies cannabis. Currently, it's known as a Schedule l drug in the eyes of the Drug Enforcement Administration (DEA), which puts it on par with drugs like heroin and methamphetamine. The designation also suggests cannabis has little to no value. The Biden administration proposal would move cannabis to a less serious Schedule lll drug, with moderate to low potential for addiction. READ MORE: https://www.king5.com/article/news/local/washington-states-cannabis-industry-federal-reclassification/281-76dc062c-3242-4e6e-8b5a-fde4eb179053